Click for best price
Postpemic Era Extremity Reconstruction Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Extremity Reconstruction Market Segment Research Report 2022, which aims to sort out the development status and trends of the Extremity Reconstruction industry at home and abroad, estimate the overall market scale of the Extremity Reconstruction industry and the market share of major countries, Extremity Reconstruction industry, and study and judge the downstream market demand of Extremity Reconstruction through systematic research, Analyze the competition pattern of Extremity Reconstruction, so as to help solve the pain points of various stakeholders in Extremity Reconstruction industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Extremity Reconstruction Market by Research Include
- USA
- Europe
- China
- Japan
- India
- Korea
- Southeast Asia
Competitive Analysis; Who are the Major Players in Extremity Reconstruction Market
- Stryker Corporation
- DePuy Synthes
- Zimmer Biomet Holdings
- Smith & Nephew
- Integra Lifesciences Holdings Corporation
- Wright Medical Group
- Acumed
- Arthrex
- CONMED Corporation
- Graftys
- Isto Biologics
- EXACtech
Major Type of Extremity Reconstruction Covered in Research report:
- Metallic Biomaterial
- Ceramic Biomaterial
- Polymeric Biomaterial
- Natural Biomaterial
Application Segments Covered in Research Market
- Upper Extremity Reconstruction
- Lower Extremity Reconstruction
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Extremity Reconstruction Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
96 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Extremity Reconstruction Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Extremity Reconstruction Market by Value
2.2.1 Global Extremity Reconstruction Revenue by Type
2.2.2 Global Extremity Reconstruction Market by Value
2.3 Global Extremity Reconstruction Market by Sales
2.3.1 Global Extremity Reconstruction Sales by Type
2.3.2 Global Extremity Reconstruction Market by Sales
3. The Major Driver of Extremity Reconstruction Industry
3.1 Historical & Forecast Global Extremity Reconstruction Sales and Revenue (2018-2028)
3.2 Largest Application for Extremity Reconstruction (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Extremity Reconstruction Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Extremity Reconstruction Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Extremity Reconstruction Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Extremity Reconstruction Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Extremity Reconstruction Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Extremity Reconstruction Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Extremity Reconstruction Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Extremity Reconstruction Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Extremity Reconstruction Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Extremity Reconstruction Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Extremity Reconstruction Average Price Trend
13.1 Market Price for Each Type of Extremity Reconstruction in US (2018-2022)
13.2 Market Price for Each Type of Extremity Reconstruction in Europe (2018-2022)
13.3 Market Price for Each Type of Extremity Reconstruction in China (2018-2022)
13.4 Market Price for Each Type of Extremity Reconstruction in Japan (2018-2022)
13.5 Market Price for Each Type of Extremity Reconstruction in India (2018-2022)
13.6 Market Price for Each Type of Extremity Reconstruction in Korea (2018-2022)
13.7 Market Price for Each Type of Extremity Reconstruction in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Extremity Reconstruction in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Extremity Reconstruction Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Extremity Reconstruction
15. Extremity Reconstruction Competitive Landscape
15.1 Stryker Corporation
15.1.1 Stryker Corporation Company Profiles
15.1.2 Stryker Corporation Product Introduction
15.1.3 Stryker Corporation Extremity Reconstruction Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 DePuy Synthes
15.2.1 DePuy Synthes Company Profiles
15.2.2 DePuy Synthes Product Introduction
15.2.3 DePuy Synthes Extremity Reconstruction Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Zimmer Biomet Holdings
15.3.1 Zimmer Biomet Holdings Company Profiles
15.3.2 Zimmer Biomet Holdings Product Introduction
15.3.3 Zimmer Biomet Holdings Extremity Reconstruction Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Smith & Nephew
15.4.1 Smith & Nephew Company Profiles
15.4.2 Smith & Nephew Product Introduction
15.4.3 Smith & Nephew Extremity Reconstruction Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Integra Lifesciences Holdings Corporation
15.5.1 Integra Lifesciences Holdings Corporation Company Profiles
15.5.2 Integra Lifesciences Holdings Corporation Product Introduction
15.5.3 Integra Lifesciences Holdings Corporation Extremity Reconstruction Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Wright Medical Group
15.6.1 Wright Medical Group Company Profiles
15.6.2 Wright Medical Group Product Introduction
15.6.3 Wright Medical Group Extremity Reconstruction Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Acumed
15.7.1 Acumed Company Profiles
15.7.2 Acumed Product Introduction
15.7.3 Acumed Extremity Reconstruction Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Arthrex
15.8.1 Arthrex Company Profiles
15.8.2 Arthrex Product Introduction
15.8.3 Arthrex Extremity Reconstruction Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 CONMED Corporation
15.9.1 CONMED Corporation Company Profiles
15.9.2 CONMED Corporation Product Introduction
15.9.3 CONMED Corporation Extremity Reconstruction Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Graftys
15.10.1 Graftys Company Profiles
15.10.2 Graftys Product Introduction
15.10.3 Graftys Extremity Reconstruction Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Isto Biologics
15.12 EXACtech
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Extremity Reconstruction Industry (Volume)
Figure 2. Extremity Reconstruction Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Extremity Reconstruction Revenue in 2022
Figure 5. US Extremity Reconstruction Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Extremity Reconstruction Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Extremity Reconstruction Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Extremity Reconstruction Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Extremity Reconstruction Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Extremity Reconstruction Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Extremity Reconstruction Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Extremity Reconstruction Revenue, by Type (Million USD) (2018-2028)
Table 4. Extremity Reconstruction Sales, by Type (K Unit) (2018-2028)
Table 5. Extremity Reconstruction Sales (K Unit) by Application (2018-2028)
Table 6. Extremity Reconstruction Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Extremity Reconstruction Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Extremity Reconstruction Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Extremity Reconstruction Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Extremity Reconstruction Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Extremity Reconstruction Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Extremity Reconstruction Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Extremity Reconstruction Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Extremity Reconstruction Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Extremity Reconstruction in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Extremity Reconstruction in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Extremity Reconstruction in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Extremity Reconstruction in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Extremity Reconstruction in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Extremity Reconstruction in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Extremity Reconstruction in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Stryker Corporation Profiles
Table 61. Stryker Corporation Extremity Reconstruction Product Introduction
Table 62. Stryker Corporation Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Stryker Corporation Strategic initiatives
Table 64. DePuy Synthes Profiles
Table 65. DePuy Synthes Extremity Reconstruction Product Introduction
Table 66. DePuy Synthes Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. DePuy Synthes Strategic initiatives
Table 68. Zimmer Biomet Holdings Profiles
Table 69. Zimmer Biomet Holdings Extremity Reconstruction Product Introduction
Table 70. Zimmer Biomet Holdings Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Zimmer Biomet Holdings Strategic initiatives
Table 72. Smith & Nephew Profiles
Table 73. Smith & Nephew Extremity Reconstruction Product Introduction
Table 74. Smith & Nephew Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Smith & Nephew Strategic initiatives
Table 76. Integra Lifesciences Holdings Corporation Profiles
Table 77. Integra Lifesciences Holdings Corporation Extremity Reconstruction Product Introduction
Table 78. Integra Lifesciences Holdings Corporation Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Integra Lifesciences Holdings Corporation Strategic initiatives
Table 80. Wright Medical Group Profiles
Table 81. Wright Medical Group Extremity Reconstruction Product Introduction
Table 82. Wright Medical Group Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Wright Medical Group Strategic initiatives
Table 84. Acumed Profiles
Table 85. Acumed Extremity Reconstruction Product Introduction
Table 86. Acumed Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Acumed Strategic initiatives
Table 88. Arthrex Profiles
Table 89. Arthrex Extremity Reconstruction Product Introduction
Table 90. Arthrex Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Arthrex Strategic initiatives
Table 92. CONMED Corporation Profiles
Table 93. CONMED Corporation Extremity Reconstruction Product Introduction
Table 94. CONMED Corporation Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. CONMED Corporation Strategic initiatives
Table 97. Graftys Profiles
Table 98. Graftys Extremity Reconstruction Product Introduction
Table 99. Graftys Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Graftys Strategic initiatives
Table 101. Isto Biologics Profiles
Table 102. Isto Biologics Extremity Reconstruction Product Introduction
Table 103. Isto Biologics Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Isto Biologics Strategic initiatives
Table 105. EXACtech Profiles
Table 106. EXACtech Extremity Reconstruction Product Introduction
Table 107. EXACtech Extremity Reconstruction Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. EXACtech Strategic initiatives
